Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Integrating cytokine profiles with clinical and molecular biomarkers to predict molecular relapse after TKI discontinuation in CML patients

Blood (2025) 146 (Supplement 1): 3785.

https://doi.org/10.1182/blood-2025-3785

Published: 2025

Journal Articles

Clinical characteristics, treatment patterns, clinical outcomes and resource utilization in patients with chronic lymphocytic leukaemia (CLL): CREEK-Latin America subgroup analysis

Miguel Pavlovsky, Milton Lombana, Macarena Roa, Efreen Horacio Montaño Figueroa, Abel Costa, Rosanny Báez, Pushpalatha Kantharaju, Akemi Ishikawa, Luis Tejado-Gallegos, Ayman Elsayes

Blood (2025) 146 (Supplement 1): 4500.

https://doi.org/10.1182/blood-2025-4500

Published: 2025

Journal Articles

Bridging the CART gap: Epcoritamab as a feasible option for relapsed/refractory DLBCL in CART-inaccessible regions - “the argentine experience”

Blood (2025) 146 (Supplement 1): 7250.

https://doi.org/10.1182/blood-2025-7250

Published: 2025

Journal Articles

ONC001: A first-in-class ADC targeting CD64 for the treatment of monocytic leukemia developed through patient-guided target and payload selection

Blood (2025) 146 (Supplement 1): 324.

https://doi.org/10.1182/blood-2025-324

Published: 2025

Journal Articles

Frontline therapy patterns and outcomes in chronic lymphocytic leukemia: A real-world, multicenter analysis from Latin America.

Celso Arrais-Rodrigues, Ana Oliver, Maria Cugliari, Luis Mario Villela Martinez, Macarena Roa, Lorena Cardozo, Marialejandra Torres Viera, Denisse Castro, Daniela Trujillo Loaiza, Leila Perobelli, Anelys García Salgado, Victoria Irigoin, Sofía Rivarola, Virginia Lema Spinelli, Jose Alvarez, Alana von Glasenapp, Camila Peña, Sally Paredes, Valeria Buccheri, Gislaine Duarte, Maura Colturato, Laura Fogliatto, Ana Ines Landoni, Sabrina ranero Ferrari, Augusto Mirolli, Marta Zerga, Miguel Pavlovsky, Nancy Cristaldo, Maria Del Rosario Custidiano, Fernando Pérez-Jacobo, Danielle De Farias, Maria Orlova, Julio Pose Cabarcos, Fernando Barroso Duarte, Etelvina Macchiavello, Sérgio Fortier, Julia Laviano, Clarisa Pagano Vilar, Nelson Hamerschlak, Vera Figueiredo, Rosa Rios Jimenez, Arianna Robles, Javier Retamales, Melanie Otañez, German Stemmelin, Henry Idrobo, Brady Beltran, Jorge Castillo, Luis Malpica, Carlos Chiattone

Blood (2025) 146 (Supplement 1): 2775.

https://doi.org/10.1182/blood-2025-2775

Published: 2025

Journal Articles

A phase 3, randomized, open-label, multicenter study of sonrotoclax (BGB-11417) plus anti-CD20 antibody therapies vs venetoclax plus rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL-RR1/CELESTIAL-RRCLL)

Blood (2025) 146 (Supplement 1): 2137.

https://doi.org/10.1182/blood-2025-2137

Published: 2025

Journal Articles

Baseline clinical characteristics of patients with chronic lymphocytic leukemia (CLL) from 11 Latin American countries: A real-world registry analysis

Ana Oliver, Celso Arrais-Rodrigues, Luis Mario Villela Martinez, Macarena Roa, Sofía Rivarola, Lorena Cardozo, Marialejandra Torres Viera, Denisse Castro, Fabiola Valvert, Daniela Trujillo Loaiza, Anelys García Salgado, Victoria Irigoin, Leila Perobelli, Silvana Cigliari, Alana von Glasenapp, Camila Peña, Sally Paredes, Valeria Buccheri, Virginia Lema Spinelli, Augusto Mirolli, Jose Alvarez, Maura Colturato, Ana Ines Landoni, Gislaine Duarte, Marta Zerga, Sabrina ranero Ferrari, Miguel Pavlovsky, Nancy Cristaldo, Laura Fogliatto, Maria Del Rosario Custidiano, Danielle De Farias, Maria Orlova, Fernando Barroso Duarte, Etelvina Macchiavello, Julio Pose Cabarcos, Sérgio Fortier, Julia Laviano, Clarisa Pagano Vilar, Nelson Hamerschlak, Vera Figueiredo, Fernando Pérez-Jacobo, Javier Retamales, Arianna Robles, German Stemmelin, Rosa Rios Jimenez, Henry Quintero, Brady Beltran, Jorge Castillo, Carlos Chiattone, Luis Malpica

Blood (2025) 146 (Supplement 1): 3908.

https://doi.org/10.1182/blood-2025-3908

Published: 2025

Journal Articles

primary Phase 3 results from the epcore FL-1 trial of epcoritamab with rituximab and lenalidomide (R2) versus R2 for relapsed or refractory follicular lymphoma

Blood (2025) 146 (Supplement 1): 466.

https://doi.org/10.1182/blood-2025-466

Published: 2025

Journal Articles

An international view on the current approaches to frontline chronic lymphocytic leukemia therapy

Guilherme Perini, Ahmad Alhuraiji, Mary Ann Anderson, Gilberto Israel Barranco Lampón, Otavio Cesar Carvalho Guimarães Baiocchi, Ahmet Emre Eskazan, Yeow Tee Goh, Wei-Han Huang, Mervat Mattar, Evgeny Nikitin, Stephen Opat, Miguel Pavlovsky, Wei Xu

Blood (2025) 146 (Supplement 1): 7937.

https://doi.org/10.1182/blood-2025-7937

Published: 2025

Journal Articles

Treatability with ibrutinib plus venetoclax in patients with CLL in the real-world. the eric international thrive study

Andrea Visentin, Thomas Chatzikonstantinou, Lydia Scarfo, Persefoni Talimtzi, Maria Angelopoulou, Tomas Arpas, Laura Ballotta, Leonidas Benetatos, Ana Margarida Bertolo, Horia Bumbea, Maurizio Cavallari, Anastasia Chatzidimitriou, Dominik Chraniuk, Anna Christoforidou, Francesca Cibien, Antonio Cuneo, Maria Ilaria del Principe, Marina Deodato, Enrico Derenzini, Michael Doubek, Fabiana Esposito, Lucia Farina, Gianmarco Favrin, Isacco Ferrarini, Annamaria Frustaci, Andrea Galitzia, Massimo Gentile, Iulia Roxana Iancu, Vanessa Innao, krzysztof jamroziak, Elzbieta Kalicinska, Maria Kislova, Ioannis Kyriakou, Luca Laurenti, Enrico Lista, Javier Loscertales, Alexandros Machairas, Giorgia Marcato, Francesca Martini, Nilla Maschio, Eva Minga, Riccardo Moia, Roberta Murru, Maura Nicolosi, Jacopo Olivieri, Carolina Pavlovsky, Miguel Pavlovsky, Sara Pepe, Ernesto Perez Persona, Giuseppe Petruzzellis, Gian Matteo Rigolin, Alessandro Sanna, Marina Siakantaris, Paolo Sportoletti, Oana Stanca, Niki Stavrogianni, Tamar Tadmor, Annamaria Tomasso, Marzia Varettoni, Theodoros Vassilakopoulos, Eva Gimeno Vazquez, Candida Vitale, Mohamed Yassin, Mihnea Zdrenghea, Klaudia Zielonka, Livio Trentin, Kostas Stamatopoulos, Paolo Ghia

Blood (2025) 146 (Supplement 1): 6287.

https://doi.org/10.1182/blood-2025-6287

Published: 2025

Journal Articles

Bcr-Abl Mutations in Chronic Myeloid Leukemia - Impact on Survival and Treatment with Second Generation Inhibitors– A Study on Behalf of Latin American Leukemia Net (Lalnet)

Blood (2011) 118 (21): 1701.

https://doi.org/10.1182/blood.V118.21.1701.1701

Published: 2011

Journal Articles

PET-CT Adapted Therapy After 3 Cycles of ABVD for All Stages of Hodgkin Lymphoma. Interim Analysis in 173 Patients

Santiago Pavlovsky, Astrid Pavlovsky, Isolda Fernandez, Miguel Pavlovsky, Virginia Prates, Lucia Zoppegno, Ana Lisa Basquiera, Ider Cerutti, Andrea Rodriguez, Gustavo Milone, Vanesa Castano, Silvia Rudoy, Federico Sackmann, Lourdes Valles, Francisco Lastiri

Blood (2010) 116 (21): 1772.

https://doi.org/10.1182/blood.V116.21.1772.1772

Published: 2010

Journal Articles

Evaluation of Prognostic Factors for Malignant Transformation of Monoclonal Gammopathy of Undetermined Significance

Federico Sackmann, Claudia Corrado, Isolda Fernandez, Miguel A Pavlovsky, Pablo Mountford, Astrid Pavlovsky, Miguel Pavlovsky, Mariel Alejandre, Marco Pizzolato, Santiago Pavlovsky, MD, PhD

Blood (2008) 112 (11): 5123.

https://doi.org/10.1182/blood.V112.11.5123.5123

Published: 2008

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Integrating cytokine profiles with clinical and molecular biomarkers to predict molecular relapse after TKI discontinuation in CML patients

Clinical characteristics, treatment patterns, clinical outcomes and resource utilization in patients with chronic lymphocytic leukaemia (CLL): CREEK-Latin America subgroup analysis

Bridging the CART gap: Epcoritamab as a feasible option for relapsed/refractory DLBCL in CART-inaccessible regions - “the argentine experience”

ONC001: A first-in-class ADC targeting CD64 for the treatment of monocytic leukemia developed through patient-guided target and payload selection

Frontline therapy patterns and outcomes in chronic lymphocytic leukemia: A real-world, multicenter analysis from Latin America.

A phase 3, randomized, open-label, multicenter study of sonrotoclax (BGB-11417) plus anti-CD20 antibody therapies vs venetoclax plus rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL-RR1/CELESTIAL-RRCLL)

Baseline clinical characteristics of patients with chronic lymphocytic leukemia (CLL) from 11 Latin American countries: A real-world registry analysis

primary Phase 3 results from the epcore FL-1 trial of epcoritamab with rituximab and lenalidomide (R2) versus R2 for relapsed or refractory follicular lymphoma

An international view on the current approaches to frontline chronic lymphocytic leukemia therapy

Treatability with ibrutinib plus venetoclax in patients with CLL in the real-world. the eric international thrive study

Bcr-Abl Mutations in Chronic Myeloid Leukemia - Impact on Survival and Treatment with Second Generation Inhibitors– A Study on Behalf of Latin American Leukemia Net (Lalnet)

PET-CT Adapted Therapy After 3 Cycles of ABVD for All Stages of Hodgkin Lymphoma. Interim Analysis in 173 Patients

Evaluation of Prognostic Factors for Malignant Transformation of Monoclonal Gammopathy of Undetermined Significance

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only